CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

Filters:
Show search box
2015-10-19
Vaccine against AIDS in Phase I clinical trials

Vaccine against AIDS in Phase I clinical trials

A vaccine based on HIV gp120 protein is a unique product for 15 years protection against infection. Unique, because it has been introduced by the team of Prof. Robert Gallo – a pioneer in the field of AIDS research and previous critic of disease-related vaccination.... Read more
Tags clinical trials , HIV , vaccine , AIDS , gp120
2015-08-12
Mutations in a cell line stops stem-cell trial to cure blindness

Mutations in a cell line stops stem-cell trial to cure blindness

Induced pluripotent stem cells (iPSC) turned into specialized retinal cells were meant to cure the damage caused by age-related macular degeneration leading to blindness. The trial was halted due to mutations identified in cells of a second patient.... Read more
Tags clinical trials , stem cells , mutations , macular degeneration , blindness , iPSC
2013-03-13 to 2015-03-12
Potential of clinical trials in CEE region

Potential of clinical trials in CEE region

Clinical trials are one of the indispensable steps of drug development. They are especially crucial for the assessment of effectiveness and safety of a novel medication. The whole pharmaceutical industry, which is growing rapidly all over the world, is trying to find new regions characterized by attr... Read more
Tags pharmaceutical , clinical trials , drug , CEE , company
Can the pepsin of pork treat HIV infection? – Clinical trials of innovative anti-HIV medici

Can the pepsin of pork treat HIV infection? – Clinical trials of innovative anti-HIV medicines in Bulgaria

On 23rd February Immunotech Laboratory announced $2M funding approval from its associate Bulgarian Immunotech Partnership Company (Immunotech BG) for clinical trials of the firm’s patented HIV-AIDS medicine. ... Read more
Tags medicine , pharmaceutical , clinical trials , bulgaria
2015-02-17
Pierre Fabre initiates Phase IIa trials for a new drug for Schizophrenia

Pierre Fabre initiates Phase IIa trials for a new drug for Schizophrenia

A French multinational company Pierre Fabre Pharmaceuticals has announced a start of Phase IIa clinical trials for a new selective antagonist of dopamine D3 receptor called F17464 in patients suffering from schizophrenia. The major aim is to determine the effectiveness and assess safety of the drug d... Read more
Tags clinical trials , drug , Pierre Fabre , schizophrenia , F17464
2014-12-31
Gene therapy in 2014

Gene therapy in 2014

The idea of gene therapy as a real therapeutic option began over 20 years ago. Since that time, there have been numerous moments of hope and disappointment that repeatedly changed the general opinion about this novel way of treatment. Today, together with advancements in human genomics, gene therapy ... Read more
Tags clinical trials , gene therapy , central Europe
2014-11-13
Clinical Trial Data more transparent

Clinical Trial Data more transparent

After lingering debates and discussions with stakeholders, the European Medicines Agency has finished a policy on the publication of clinical data regarding medical products for human use. The system that will allow future investigation of clinical trial information is not free from controversies.... Read more
Tags EMA , clinical trials , healthcare , data , policy
2014-04-11
Expert from Teva Pharmaceuticals about advantages of conducting clinical trials in CEE

Expert from Teva Pharmaceuticals about advantages of conducting clinical trials in CEE

There are plenty of Contract Research Organizations operating in Central and Eastern Europe (CEE) region. Pharmaceutical giants from all around the world are conducting clinical trails connected to development of their novel pharmaceuticals with their assistance, often preferring them over domestic c... Read more
Tags clinical trials , bioforum 2014 , Teva , Teva Pharmaceuticals , Yatif Stark
2014-02-05
The CEE region rising importance in bio-similar and bio-equivalent studies - KCR experts st

The CEE region rising importance in bio-similar and bio-equivalent studies - KCR experts statements

The region of Central & Eastern Europe (CEE) has been growing dynamically as a life science market since mid-1990s. With high productivity and quality standards, the CEE market attracts more and more companies looking for reliable partners. KCR will lead a panel on clinical research in CEE during the... Read more
Tags medicine , clinical trials , CRO , drug development
2013-12-24
 Political agreement on the draft EU Clinical Trials Regulation could enhance regulatory fr

Political agreement on the draft EU Clinical Trials Regulation could enhance regulatory framework for clinical trials, but is not ambitious enough.

EuropaBio welcomes the political agreement on the draft Clinical Trials Regulation by the EU Committee of Permanent Representatives (COREPER) today, thus paving the way for the adoption of the Regulation by the co-legislators, the European Parliament and the Council, in 2014. The Clinical Trials Reg... Read more
Tags clinical trials , EuropaBio , European Parliament
Sandoz begins Phase III clinical trial for biosimilar adalimumab

Sandoz begins Phase III clinical trial for biosimilar adalimumab

Sandoz, the global leader in biosimilars, announced it has initiated a Phase III clinical trial with its biosimilar version of adalimumab (AbbVie’s HUMIRA®) – the leading treatment of several autoimmune conditions including rheumatoid arthritis, psoriasis, and Crohn’s disease. ... Read more
Tags biosimilars , clinical trials , Sandoz , adalimumab
2013-11-28
Transylvanian artificial blood made from sea worms

Transylvanian artificial blood made from sea worms

Transylvanian scientists are on the verge of inventing the artificial blood. In the Cluj-Napoca, the second most populous city in Romania the six-year experiment on mice was finished with no harmful side effects found. It was not only accepted by their bodies, but also did not caused any inflammation... Read more
Tags romania , clinical trials , blood , artificial blood , blood substitutes , preclinical
2013-04-05
"Steersman through the non-clinical development path"  - the interview with Dr. Emmanuelle

"Steersman through the non-clinical development path" - the interview with Dr. Emmanuelle Cornali, Head of Business Development of Aurigon Life Science

Aurigon Life Science is a full service contract research organisation offering optimized and tailor-made solutions from candidate to marketed product. With the experience of over 30 years in R&D area and having a multidisciplinary team of experts based in Munich and in Budapest, Aurigon is an importa... Read more
Tags hungary , , clinical trials , germany , CRO